HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J

This article was originally published in The Rose Sheet

Executive Summary

Aveeno Facial Care sell-in contributed to first quarter 5% skin care sales increase (9% excluding currency), firm reports during analyst call April 17. Soy-based line began rolling out in mass outlets in March (1"The Rose Sheet" March 12, p. 3). Neutrogena and Clean & Clear also saw solid growth, J&J says. New Evian Affinity face and body care products in France contributed to gains; J&J is "evaluating opportunities" for Evian in other markets, including U.S. Formulated with patented technology "designed to address skin's essential needs by providing [it] with air, water and nutrients," collection debuted in March in alliance with French bottled water manufacturer Danone. J&J worldwide consumer segment sales grew 5.5% to $1.8 bil. in first quarter. Consolidated sales grew 6.5% to $7.79 bil.; net earnings jumped 14.2% to $1.5 bil

You may also be interested in...



Evian Affinity Skin Care Tests U.S. Waters On Drugstore.com

Johnson & Johnson appears to be testing the viability of its Evian Affinity skin care brand in the U.S. market through an exclusive launch on the e-commerce health and beauty site Drugstore.com

Evian Affinity Skin Care Tests U.S. Waters On Drugstore.com

Johnson & Johnson appears to be testing the viability of its Evian Affinity skin care brand in the U.S. market through an exclusive launch on the e-commerce health and beauty site Drugstore.com

J&J Neutrogena, RoC Extensions Aim To Fuel Skin Care Gains In Second Half

Neutrogena and RoC skin care launches planned for the second half of the year are expected to help Johnson & Johnson regain category growth following disappointing second quarter sales in the sector, the company said.

UsernamePublicRestriction

Register

MT125590

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel